tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tejas Savant, 74 are a HOLD (39.15%), 11 are a SELL (5.82%), 104 are a BUY (55.03%).
Analyst Tejas Savant, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 35.78% that have a potential upside of 20.44% achieved within 83 days.
Tejas Savant’s has documented 413 price targets and ratings displayed on 32 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on VCYT, Veracyte at 18-Nov-2024.
Analyst best performing recommendations are on NVTA (INVITAE CORP).
The best stock recommendation documented was for NSTG (NANOSTRING TECHNOLOGIES) at 11/10/2020. The price target of $44 was fulfilled within 1 day with a profit of $4.58 (11.62%) receiving and performance score of 116.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$7
$1.04 (17.45%)
$6
21 days ago
(11-Nov-2024)
6/11 (54.55%)
$0.51 (7.86%)
108
Buy
$8
$2.04 (34.23%)
$5
2 months ago
(02-Oct-2024)
3/7 (42.86%)
$2.86 (55.64%)
97
Hold
$5
$-0.96 (-16.11%)
$63
9 months 16 days ago
(16-Feb-2024)
2/3 (66.67%)
$1.15 (29.87%)
213
Hold
$10
$4.04 (67.79%)
$13
1 years 1 months 8 days ago
(24-Oct-2023)
1/6 (16.67%)
$5.31 (113.22%)
5
Sell
$7
$1.04 (17.45%)
$8
1 years 9 months 17 days ago
(15-Feb-2023)
2/2 (100%)
$-3.03 (-30.21%)
50
Which stock is Tejas Savant is most bullish on?
Which stock is Tejas Savant is most reserved on?
What Year was the first public recommendation made by Tejas Savant?
